Lux Health Technologies Ltd 10065887 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is a dormant company Digita Accounts Production Advanced 6.30.9574.0 true true 10065887 2025-01-01 2025-12-31 10065887 2025-12-31 10065887 bus:OrdinaryShareClass1 2025-12-31 10065887 core:RetainedEarningsAccumulatedLosses 2025-12-31 10065887 core:ShareCapital 2025-12-31 10065887 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 10065887 bus:SmallEntities 2025-01-01 2025-12-31 10065887 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 10065887 bus:FilletedAccounts 2025-01-01 2025-12-31 10065887 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 10065887 bus:RegisteredOffice 2025-01-01 2025-12-31 10065887 bus:Director2 2025-01-01 2025-12-31 10065887 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 10065887 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 10065887 1 2025-01-01 2025-12-31 10065887 countries:EnglandWales 2025-01-01 2025-12-31 10065887 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 10065887 2024-01-01 2024-12-31 10065887 bus:OrdinaryShareClass1 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10065887

Lux Health Technologies Ltd
Annual Report and Unaudited Financial Statements
for the Year Ended 31 December 2025

Pages for filing with Registrar

Lux Health Technologies Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 4

Lux Health Technologies Ltd

Company Information

Director | A K Shirley

Registered office | 16 Queen Anne's Gate London SW1H 9AA

Registered number | 10065887

Accountant | Corrigan Accountants Limited 1st Floor 25 King Street Bristol BS1 4PB

Lux Health Technologies Ltd

(Registration number: 10065887)
Balance Sheet as at 31 December 2025

| Note | 2025 £ | 2024 £
Capital and reserves |  |  |
Called up share capital |  | 10 | 10
Profit and loss account |  | (10) | (10)
Total equity |  | - | -

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised for issue by the director on 22 April 2026

.........................................

A K Shirley
Director

Lux Health Technologies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1 | Statutory information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
16 Queen Anne's Gate
London
SW1H 9AA

2 | Accounting policies

Summary of significant accounting policies

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention.
The financial statements are prepared in pounds sterling which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year was 1 (2024 - 1).

Lux Health Technologies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

4 | Intangible fixed assets

| Development costs £
Cost
At 1 January 2025 | 1,389,665
At 31 December 2025 | 1,389,665
Amortisation
At 1 January 2025 | 1,389,665
At 31 December 2025 | 1,389,665
Carrying amount
At 31 December 2025 | -

5 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £1 each | 10 | 10 | 10 | 10

6 | Parent and ultimate parent undertaking

The company's immediate parent is Nine United Properties UK Ltd, a company incorporated in England and Wales.